Cargando…

Nanoscale metal–organic frameworks as photosensitizers and nanocarriers in photodynamic therapy

Photodynamic therapy (PDT) is a new therapeutic system for cancer treatment that is less invasive and offers greater selectivity than chemotherapy, surgery, and radiation therapy. PDT employs irradiation light of known wavelength to excite a photosensitizer (PS) agent that undergoes photochemical re...

Descripción completa

Detalles Bibliográficos
Autores principales: Matlou, Gauta Gold, Abrahamse, Heidi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458963/
https://www.ncbi.nlm.nih.gov/pubmed/36092660
http://dx.doi.org/10.3389/fchem.2022.971747
_version_ 1784786395897790464
author Matlou, Gauta Gold
Abrahamse, Heidi
author_facet Matlou, Gauta Gold
Abrahamse, Heidi
author_sort Matlou, Gauta Gold
collection PubMed
description Photodynamic therapy (PDT) is a new therapeutic system for cancer treatment that is less invasive and offers greater selectivity than chemotherapy, surgery, and radiation therapy. PDT employs irradiation light of known wavelength to excite a photosensitizer (PS) agent that undergoes photochemical reactions to release cytotoxic reactive oxygen species (ROS) that could trigger apoptosis or necrosis-induced cell death in tumor tissue. Nanoscale metal–organic frameworks (NMOFs) have unique structural advantages such as high porosity, large surface area, and tunable compositions that have attracted attention toward their use as photosensitizers or nanocarriers in PDT. They can be tailored for specific drug loading, targeting and release, hypoxia resistance, and with photoactive properties for efficient response to optical stimuli that enhance the efficacy of PDT. In this review, an overview of the basic chemistry of NMOFs, their design and use as photosensitizers in PDT, and as nanocarriers in synergistic therapies is presented. The review also discusses the morphology and size of NMOFs and their ability to improve photosensitizing properties and localize within a targeted tissue for effective and selective cancer cell death over healthy cells. Furthermore, targeting strategies that improve the overall PDT efficacy through stimulus-activated release and sub-cellular internalization are outlined with relevance to in vitro and in vivo studies from recent years.
format Online
Article
Text
id pubmed-9458963
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94589632022-09-10 Nanoscale metal–organic frameworks as photosensitizers and nanocarriers in photodynamic therapy Matlou, Gauta Gold Abrahamse, Heidi Front Chem Chemistry Photodynamic therapy (PDT) is a new therapeutic system for cancer treatment that is less invasive and offers greater selectivity than chemotherapy, surgery, and radiation therapy. PDT employs irradiation light of known wavelength to excite a photosensitizer (PS) agent that undergoes photochemical reactions to release cytotoxic reactive oxygen species (ROS) that could trigger apoptosis or necrosis-induced cell death in tumor tissue. Nanoscale metal–organic frameworks (NMOFs) have unique structural advantages such as high porosity, large surface area, and tunable compositions that have attracted attention toward their use as photosensitizers or nanocarriers in PDT. They can be tailored for specific drug loading, targeting and release, hypoxia resistance, and with photoactive properties for efficient response to optical stimuli that enhance the efficacy of PDT. In this review, an overview of the basic chemistry of NMOFs, their design and use as photosensitizers in PDT, and as nanocarriers in synergistic therapies is presented. The review also discusses the morphology and size of NMOFs and their ability to improve photosensitizing properties and localize within a targeted tissue for effective and selective cancer cell death over healthy cells. Furthermore, targeting strategies that improve the overall PDT efficacy through stimulus-activated release and sub-cellular internalization are outlined with relevance to in vitro and in vivo studies from recent years. Frontiers Media S.A. 2022-08-26 /pmc/articles/PMC9458963/ /pubmed/36092660 http://dx.doi.org/10.3389/fchem.2022.971747 Text en Copyright © 2022 Matlou and Abrahamse. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Chemistry
Matlou, Gauta Gold
Abrahamse, Heidi
Nanoscale metal–organic frameworks as photosensitizers and nanocarriers in photodynamic therapy
title Nanoscale metal–organic frameworks as photosensitizers and nanocarriers in photodynamic therapy
title_full Nanoscale metal–organic frameworks as photosensitizers and nanocarriers in photodynamic therapy
title_fullStr Nanoscale metal–organic frameworks as photosensitizers and nanocarriers in photodynamic therapy
title_full_unstemmed Nanoscale metal–organic frameworks as photosensitizers and nanocarriers in photodynamic therapy
title_short Nanoscale metal–organic frameworks as photosensitizers and nanocarriers in photodynamic therapy
title_sort nanoscale metal–organic frameworks as photosensitizers and nanocarriers in photodynamic therapy
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458963/
https://www.ncbi.nlm.nih.gov/pubmed/36092660
http://dx.doi.org/10.3389/fchem.2022.971747
work_keys_str_mv AT matlougautagold nanoscalemetalorganicframeworksasphotosensitizersandnanocarriersinphotodynamictherapy
AT abrahamseheidi nanoscalemetalorganicframeworksasphotosensitizersandnanocarriersinphotodynamictherapy